Health-Related Quality of Life and Side Effects in Gastrointestinal Stromal Tumor (GIST) Patients Treated with Tyrosine Kinase Inhibitors: A Systematic Review of the Literature

SIMPLE SUMMARY: Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal tumors of the gastrointestinal tract, mostly driven by activating mutations in KIT or PDGFRα oncogenes. The introduction of tyrosine kinase inhibitors (TKIs) has revolutionized the treatment of GIST resulting in...

Descripción completa

Detalles Bibliográficos
Autores principales: van de Wal, Deborah, Elie, Mai, Le Cesne, Axel, Fumagalli, Elena, den Hollander, Dide, Jones, Robin L., Marquina, Gloria, Steeghs, Neeltje, van der Graaf, Winette T. A., Husson, Olga
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8997462/
https://www.ncbi.nlm.nih.gov/pubmed/35406604
http://dx.doi.org/10.3390/cancers14071832

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8997462/
https://www.ncbi.nlm.nih.gov/pubmed/35406604
http://dx.doi.org/10.3390/cancers14071832

Ejemplares similares